StemCell Therapy

Phoenix,AZ(October 11, 2019) AxolotlBiologix, an innovative biotechnology leader in regenerative medicine,announced it has obtained HealthcareCommon Procedure Coding System (HCPCS) billing codes from the Centers forMedicare and Medicaid Services (CMS) for all its products effective October 1,2019.

Were thrilled that the CMS has made it easier forhealthcare providers to get reimbursed for treatments using Axolotl products,said Gary Lauterbach, CEO of AxolotlBiologix. Axolotls products are already part of the GSAs FederalSupply Schedule and areavailable through Indian Health Services and Veterans Affairs. Issuance of these HCPCS Q-Codes by CMS will help simplify thereimbursement process making it easier to utilize our regenerative products.

AxolotlsDualGraft and Axolotl Graft products have been assigned the code Q4210.Axolotls DualGraft is a bi-layered human amnion membrane patch that protectswounds while serving as a barrier to help encourage skin repair andreconstruction. DualGraft is a double-layered amniotic membrane convenientlypackaged as a dehydrated allograft, which can be stored at room temperature andapplied without special instruments in a clinical setting.

AxolotlAmbient and Axolotl Cryo products were assigned the code Q4215. AxolotlAmbient and Axolotl Cryo products are liquid allografts derived from theamniotic components of the placenta to promote regeneration and repair ofdamaged or degenerated tissue. The Ambient product is a liquid allograft that can be stored at an ambienttemperature (257C, 7713F).

For more information on Axolotl products visit http://www.axobio.com

About Axolotl Biologix:

Axolotl Biologix, Inc.is an innovative biotechnology leader in regenerative medicine throughresearch, technology and clinical application. Axolotl Biologix is expandingthe human bodys ability to regenerate by developing and manufacturingregenerative human cell and tissue medical technologies that are disruptingtraditional, more invasive, painful and expensive treatment protocols. For moreinformation, visit http://www.axobio.com

Media Contact:

JoshWeiss

10 to 1Public Relations

josh@10to1pr.com

480-789-0743

Read the original here:
Centers for Medicare and Medicaid Services Makes It Easier for Healthcare Providers to Choose Axolotl Biologix Products to Spur Wound and Tissue...

This entry was posted on October 28, 2019 at 12:45 am and is filed under Regenerative Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |